This was the stock's third consecutive day of losses.

This was the stock's second consecutive day of losses.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Between February 3, 2025, and February 7, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will ...

Shares of NASDAQ INO opened at $1.98 on Friday. The company has a market capitalization of $51.68 million, a PE ratio of -0.95 and a beta of 0.84. Inovio Pharmaceuticals has a twelve month low of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Conduent Incorporated , a global technology-led business solutions and services company, today announced that the Oklahoma State Department of Health (OSDH) has selected the company's Maven® Disease ...